Brandon Capital
Provider of seed and venture capital for life science companies
About This Fund
Provider of seed and venture capital for life science companies. It supports companies from proof-of-concept to commercialization, partnering with entrepreneurs for long-term growth. Investments focus on developing medical innovations, aiming for strong financial returns and improved patient outcomes. The firm offers co-investment arrangements, expanding its capacity to support portfolio companies. It invests early, often serving as the founding investor.
Investment Focus
What They Look For
Associated with member research institutes via Brandon BioCatalyst (primarily Australia/NZ), promising biomedical innovations from proof-of-concept to late-stage with strong commercial potential; invests in ANZ startups and international scale-ups (US, UK, Europe); prefers science-driven opportunities in life sciences
Preparing to pitch Brandon Capital?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →